Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
14 June 2023Website:
http://www.calcimedica.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:51:04 GMTDividend
Analysts recommendations
Institutional Ownership
CALC Latest News
Conference call and webcast to be held tomorrow, June 27, 2024 at 8:30 a.m. ET/ 5:30 a.m.
What type of business is CalciMedica?
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
What sector is CalciMedica in?
CalciMedica is in the Healthcare sector
What industry is CalciMedica in?
CalciMedica is in the Biotechnology industry
What country is CalciMedica from?
CalciMedica is headquartered in United States
When did CalciMedica go public?
CalciMedica initial public offering (IPO) was on 14 June 2023
What is CalciMedica website?
https://www.calcimedica.com
Is CalciMedica in the S&P 500?
No, CalciMedica is not included in the S&P 500 index
Is CalciMedica in the NASDAQ 100?
No, CalciMedica is not included in the NASDAQ 100 index
Is CalciMedica in the Dow Jones?
No, CalciMedica is not included in the Dow Jones index
When does CalciMedica report earnings?
The next expected earnings date for CalciMedica is 09 August 2024